About MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation is a company based in Pudong (China) founded in 2015.. MicroPort CardioFlow Medtech Corporation has raised $132.02 million across 4 funding rounds from investors including CICC, SDIC and Lake Bleu Capital. The company has 430 employees as of December 31, 2024. MicroPort CardioFlow Medtech Corporation operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Pudong, China
- Employees 430 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Microport Cardioflow Medtech Corporation
-
Annual Revenue
$50.48 M (USD)5.52as on Dec 31, 2024
-
Net Profit
$-6.9 M (USD)89.71as on Dec 31, 2024
-
EBITDA
$-5.21 M (USD)83.88as on Dec 31, 2024
-
Total Equity Funding
$132.02 M (USD)
in 4 rounds
-
Latest Funding Round
$130 M (USD), Series C
Apr 15, 2020
-
Investors
CICC
& 8 more
-
Employee Count
430
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation is a publicly listed company on the HKEX with ticker symbol 2160 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation has successfully raised a total of $132.02M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $130 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $130.0M
-
First Round
First Round
(16 Aug 2016)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Series C - MicroPort CardioFlow Medtech Corporation | Valuation | Lake Bleu Capital | |
| Dec, 2017 | Amount | Series B - MicroPort CardioFlow Medtech Corporation | Valuation | SDIC |
|
| Oct, 2017 | Amount | Series A - MicroPort CardioFlow Medtech Corporation | Valuation | Huatai Zijin Investment , CICC |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include CICC, SDIC and Lake Bleu Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Acquisitions are targeted by CPE as a private equity firm.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MicroPort CardioFlow Medtech Corporation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MicroPort CardioFlow Medtech Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microport Cardioflow Medtech Corporation Comparisons
Competitors of MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Microport Cardioflow Medtech Corporation
Frequently Asked Questions about MicroPort CardioFlow Medtech Corporation
When was MicroPort CardioFlow Medtech Corporation founded?
MicroPort CardioFlow Medtech Corporation was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is MicroPort CardioFlow Medtech Corporation located?
MicroPort CardioFlow Medtech Corporation is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
Is MicroPort CardioFlow Medtech Corporation a funded company?
MicroPort CardioFlow Medtech Corporation is a funded company, having raised a total of $132.02M across 4 funding rounds to date.
How many employees does MicroPort CardioFlow Medtech Corporation have?
As of Dec 31, 2024, the latest employee count at MicroPort CardioFlow Medtech Corporation is 430.
What is the annual revenue of MicroPort CardioFlow Medtech Corporation?
Annual revenue of MicroPort CardioFlow Medtech Corporation is $50.48M as on Dec 31, 2024.
What does MicroPort CardioFlow Medtech Corporation do?
Founded in 2015 and based in Pudong, China, the company operates in the medtech sector with a focus on devices for heart valve conditions. Transcatheter aortic valve implantation products, such as VitaFlow for treating aortic stenosis in elderly patients, are provided. Additional offerings include the Alwide Aoguang valve balloon dilation catheter for surgical aortic valve replacement and the Alpass Ao Shun catheter sheath kit, among others.
Who are the top competitors of MicroPort CardioFlow Medtech Corporation?
MicroPort CardioFlow Medtech Corporation's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Is MicroPort CardioFlow Medtech Corporation publicly traded?
Yes, MicroPort CardioFlow Medtech Corporation is publicly traded on HKEX under the ticker symbol 2160.
Who are MicroPort CardioFlow Medtech Corporation's investors?
MicroPort CardioFlow Medtech Corporation has 9 investors. Key investors include CICC, SDIC, Lake Bleu Capital, CPE, and CDG Capital.
What is MicroPort CardioFlow Medtech Corporation's ticker symbol?
The ticker symbol of MicroPort CardioFlow Medtech Corporation is 2160 on HKEX.
What is MicroPort CardioFlow Medtech Corporation's valuation?
The valuation of MicroPort CardioFlow Medtech Corporation is $2.02M as of Aug 2016.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.